filed-within
New drugs fuel strong Pfizer results; company raises 2016 forecasts
May 3, 2016 by elegant · Leave a Comment
Pfizer said sales would be hurt in the fourth quarter of 2016, however, when those added days will be offset by fewer days. Pfizer walked away from the deal after the U.S. Treasury issued new rules curbing tax inversion deals, under which American companies move overseas to cut taxes. Many analysts believe Pfizer needs to buy new medicines or entire biotech companies to ensure competitive earnings growth.
Read more here:
New drugs fuel strong Pfizer results; company raises 2016 forecasts
filed-within
U.S. prosecutors consider more charges against ex-CEO Shkreli
May 3, 2016 by admin · Leave a Comment
NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor
Read more from the original source:
U.S. prosecutors consider more charges against ex-CEO Shkreli